Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nadler, J. L.
Right arrow Articles by Rude, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nadler, J. L.
Right arrow Articles by Rude, R. K.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 15, Issue 7 835-841, Copyright © 1992 by American Diabetes Association


ARTICLES

Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus

JL Nadler, S Malayan, H Luong, S Shaw, RD Natarajan and RK Rude
Department of Diabetes, Endocrinology and Metabolism, City of Hope National Medical Center, Duarte, California 91010.

OBJECTIVE--Mg deficiency may be an important factor leading to cardiovascular disease. Diabetic subjects show an increase in platelet reactivity that can enhance the risks of vascular disease. In addition, diabetic patients have been reported to be at risk of developing extracellular Mg deficiency. However, the intracellular free Mg concentration and its role in the enhanced platelet reactivity in diabetes is not known. RESEARCH DESIGN AND METHODS--We evaluated the intracellular erythrocyte (RBC) Mg2+ concentration in 20 non-insulin-dependent (type II) diabetics. In addition, the effects of intravenous 3-h drip or 8 wk of oral Mg supplementation on intracellular RBC Mg2+ levels and platelet reactivity was studied. To more clearly evaluate the direct role of Mg in these effects, we induced isolated Mg deficiency in 16 nondiabetic control subjects with an Mg-free liquid diet for 3 wk. RESULTS--The intracellular RBC Mg2+ concentration of diabetic patients was significantly reduced compared with values in nondiabetic control subjects (166 +/- 7 vs. 204 +/- 7 microM, P less than 0.01). Serum Mg levels were also reduced in the diabetic patients compared with the control subjects (1.59 +/- 0.04 vs. 1.9 +/- 0.1 mEq/L, P less than 0.05). Oral Mg supplementation for 8 wk (400 mg/day) restored RBC Mg2+ concentration to normal without significantly changing serum Mg concentration. Both intravenous and oral Mg supplementation markedly reduced platelet reactivity in response to the thromboxane A2 analog, U46619. The Mg-free diet resulted in a significant reduction in RBC Mg2+ concentration and markedly enhanced the sensitivity of platelet aggregation to U46619 and ADP. CONCLUSIONS--These results suggest that type II diabetic patients have intracellular Mg2+ deficiency and that Mg deficiency may be a key factor in leading to enhanced platelet reactivity in type II diabetes. Therefore, Mg supplementation may provide a new therapeutic approach to reducing vascular disease in patients with diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. M. Duke, P. M. Hopkins, P. J. Halsall, and D. S. Steele
Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia
Br. J. Anaesth., September 1, 2006; 97(3): 320 - 328.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
D. K. Plante and J. L. Nadler
Diabetes and Vascular Disease
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2003; 7(3): 295 - 310.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
A. L. Peters and W. Hsueh
Antihypertensive Agents in Diabetic Patients: Great Benefits, Special Risks
Arch Intern Med, March 22, 1999; 159(6): 541 - 542.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. A Khan, A. M. Alam, L. Ali, A. Goswami, Z. Hassan, S. Sattar, N. G Banik, and A. A. Khan
Serum and urinary magnesium in young diabetic subjects in Bangladesh
Am. J. Clinical Nutrition, January 1, 1999; 69(1): 70 - 73.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Dominguez, M. Barbagallo, J. R. Sowers, and L. M. Resnick
Magnesium Responsiveness to Insulin and Insulin-Like Growth Factor I in Erythrocytes from Normotensive and Hypertensive Subjects
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4402 - 4407.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
J. R. Sowers
Diabetes Mellitus and Cardiovascular Disease in Women
Arch Intern Med, March 23, 1998; 158(6): 617 - 621.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. R. Sowers and M. Epstein
Diabetes Mellitus and Associated Hypertension, Vascular Disease, and Nephropathy : An Update
Hypertension, December 1, 1995; 26(6): 869 - 879.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1992 by the American Diabetes Association.